Novartis Bioventures Ltd filings

This page lists the SEC filings reported by Novartis Bioventures Ltd.

SEC filings by Novartis Bioventures Ltd ()
TypeFiled
SC 13D/A2018-04-17EDGAR
42018-03-19EDGAR
42018-02-15EDGAR
SC 13G/A2018-02-02EDGAR
SC 13G/A2018-02-02EDGAR
SC 13G/A2018-02-02EDGAR
42018-01-19EDGAR
42017-12-15EDGAR
42017-11-16EDGAR
SC 13G/A2017-11-07EDGAR
42017-08-23EDGAR
SC 13G/A2017-08-23EDGAR
42017-07-05EDGAR
SC 13D2017-07-05EDGAR
32017-06-28EDGAR
42017-06-20EDGAR
42017-06-12EDGAR
42017-06-08EDGAR
42017-06-06EDGAR
42017-06-02EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.